These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3914866)

  • 41. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Passive hemagglutination tests with Shigella flexneri and Shigella sonnei antigens in the diagnosis of dysentery].
    Prokopowicz D
    Wiad Lek; 1972 Jul; 25(11):977-80. PubMed ID: 4557140
    [No Abstract]   [Full Text] [Related]  

  • 43. Binding of enteric bacteria to hog gastric mucin.
    Kétyi I
    Acta Microbiol Hung; 1990; 37(1):45-53. PubMed ID: 1702253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muramylpeptide shedding modulates cell sensing of Shigella flexneri.
    Nigro G; Fazio LL; Martino MC; Rossi G; Tattoli I; Liparoti V; De Castro C; Molinaro A; Philpott DJ; Bernardini ML
    Cell Microbiol; 2008 Mar; 10(3):682-95. PubMed ID: 18042252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a.
    Pore D; Chowdhury P; Mahata N; Pal A; Yamasaki S; Mahalanabis D; Chakrabarti MK
    Vaccine; 2009 Sep; 27(42):5855-64. PubMed ID: 19660587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
    Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA
    J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ShiA abrogates the innate T-cell response to Shigella flexneri infection.
    Ingersoll MA; Zychlinsky A
    Infect Immun; 2006 Apr; 74(4):2317-27. PubMed ID: 16552062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dynamics of bacterial polysensitization in acute dysentery in children depending on the species of the causative agent].
    Karavaev VE
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):72-5. PubMed ID: 3296580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection.
    Kim JO; Rho S; Kim SH; Kim H; Song HJ; Kim EJ; Kim RY; Kim EH; Sinha A; Dey A; Yang JS; Song MK; Nandy RK; Czerkinsky C; Kim DW
    Clin Vaccine Immunol; 2015 Apr; 22(4):381-8. PubMed ID: 25651919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of tumor necrosis factor and interleukin 6 by outer membrane proteins of Shigella in spleen cells and macrophages of mice.
    Czarny A; Witkowska D; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1993; 41(2):153-7. PubMed ID: 8239920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinico-diagnostic significance of specific antigenemia in acute dysentery].
    Abdurakhmanova EG; Timina VP; Shabalina SV
    Sov Med; 1984; (5):114-6. PubMed ID: 6205453
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies on acquired systemic resistance in mice with oral immunization with Shigella sonnei.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):345-55. PubMed ID: 7004395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparative susceptibility of animals to Sonne and Flexner dysentery].
    Suptel' IeO; Maksymovych NO; Borysov VA
    Mikrobiol Zh; 1976; 38(6):706-710. PubMed ID: 794642
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunity against dysentery after enteral immunization with live vaccine.
    Denchev V; Trifonova A; Jeleva M; Duncheva S; Bratanova V; Dimitrova Z; Kovachev P
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):71-4. PubMed ID: 4613140
    [No Abstract]   [Full Text] [Related]  

  • 55. Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge.
    Vecino WH; Quanquin NM; Martinez-Sobrido L; Fernandez-Sesma A; García-Sastre A; Jacobs WR; Fennelly GJ
    Virology; 2004 Aug; 325(2):192-9. PubMed ID: 15246259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on biochemical variants of Sh. flexneri. II. Studies on mannitol negative variants of Sh. flexneri 3a.
    Trifonova A; Pencheva P; Tekelieva R; Hashumova I
    Zentralbl Bakteriol Orig A; 1974 Mar; 226(3):349-54. PubMed ID: 4151799
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral immunization against dysentery.
    Kétyi I; Rauss K; Vertényi A
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):81-5. PubMed ID: 4613142
    [No Abstract]   [Full Text] [Related]  

  • 58. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Identification of specific antibodies in dysentery].
    Bunin KV; Belaia OF
    Sov Med; 1984; (10):19-22. PubMed ID: 6393359
    [No Abstract]   [Full Text] [Related]  

  • 60. Self-experiments with ingestion of various bacteria.
    Rédey B
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):45-62. PubMed ID: 4216252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.